DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...
Unpack why persistent communication breakdowns between sponsors, CROs, and sites undermine startup efficiency—and how ...
Clinical research organization ICON plc (NASDAQ:ICLR) announced its financial guidance for fiscal year 2025 on Tuesday. What Happened: The Dublin-based company forecasts revenues of $8.05 billion — $8 ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...
Baron Funds, an investment management company, released its “Baron Small Cap Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the second quarter of 2025, the ...
We recently published a list of 10 AI News and Ratings Too Important to Miss. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against other AI ...
Shares of companies that conduct drug trials on behalf of pharmaceutical companies, such as Icon (ICLR), Iqvia (IQV), and Medpace (MEDP), are trading lower following a media report stating the Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback